Skip to main content
Premium Trial:

Request an Annual Quote

LadaTech Serves Illumina with IP Infringement Suit

NEW YORK (GenomeWeb News) – LadaTech said after the close of the market yesterday that it has served Illumina with its previously filed patent infringement suit.

The Larchmont, NY-based firm, which is jointly owned by GlaxoSmithKline and IP Finance Holdings, initially filed the suit in August.

Specifically, LadaTech alleges that Illumina's Genome Analyzer and related products and services infringe US Patent 6,107,023, "DNA Amplification and Subtraction Techniques," which was issued in 2000. The patent, which includes among its claims a "method of amplifying a mixture of DNA fragments by repeated linker/primer replication," was originally assigned to Genelabs, which GlaxoSmithKline acquired in January for $57 million.

LadaTech claims in the suit that it now owns all rights to the patent, which was the subject of a re-examination request filed by a third party on behalf of Illumina in January 2008.

"We have sought to grant a license to Illumina on reasonable terms, but Illumina has refused to enter into a license agreement and to pay what it owes for its infringing use of the '023 patent invention," LadaTech President and CEO Nicholas Didier said in a statement. "Based on this refusal, LadaTech has concluded that litigation is its only remaining option to protect its intellectual property."

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.